66 related articles for article (PubMed ID: 22704241)
1. Immunomodulatory role of TIITS in respect to cytotoxic lymphocytes in four grades of human glioma.
Kumar P; Acharya S; Chatterjee S; Kumari A; Chaudhuri S; Singh MK; Ghosh SN; Chaudhuri S
Cell Immunol; 2012; 276(1-2):176-86. PubMed ID: 22704241
[TBL] [Abstract][Full Text] [Related]
2. Significant modulation of macrophages associated cytokines TNF-α, VEGF and apoptotoic protein Bax, Bcl2 abrogates tumor cells.
Kumar P; Chatterjee S; Acharya S; Kumari A; Chaudhuri S; Singh MK; Ghosh SN; Chaudhuri S
Cell Immunol; 2013; 284(1-2):172-81. PubMed ID: 23994239
[TBL] [Abstract][Full Text] [Related]
3. T11 target structure exerts effector function by activating immune cells in CNS against glioma where cytokine modulation provide favorable microenvironment.
Ghosh A; Bhattacharya M; Sarkar P; Acharya S; Chaudhuri S
Indian J Exp Biol; 2010 Sep; 48(9):879-88. PubMed ID: 21506495
[TBL] [Abstract][Full Text] [Related]
4. Bax and Bid act in synergy to bring about T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation.
Bhattacharjee M; Acharya S; Ghosh A; Sarkar P; Chatterjee S; Kumar P; Chaudhuri S
Int Immunol; 2008 Dec; 20(12):1489-505. PubMed ID: 18931364
[TBL] [Abstract][Full Text] [Related]
5. Induction of G1 arrest in glioma cells by T11TS is associated with upregulation of Cip1/Kip1 and concurrent downregulation of cyclin D (1 and 3).
Acharya S; Chatterjee S; Kumar P; Bhattacharjee M; Chaudhuri S; Chaudhuri S
Anticancer Drugs; 2010 Jan; 21(1):53-64. PubMed ID: 19829098
[TBL] [Abstract][Full Text] [Related]
6. T11TS repress gliomagenic apoptosis of bone marrow hematopoietic stem cells.
Mondal S; Hazra I; Datta A; Sk Md OF; Moitra S; Tripathi SK; Chaudhuri S
J Cell Physiol; 2018 Jan; 233(1):269-290. PubMed ID: 28233371
[TBL] [Abstract][Full Text] [Related]
7. The "erythrocyte receptor" of T-lymphocytes and T11 target structure (T11TS): complementary cell interaction molecules involved in T-cell activation.
Hünig T; Tiefenthaler G; Mitnacht R; Köhler C; Lottspeich F; Meuer S
Behring Inst Mitt; 1987 Jun; (81):31-40. PubMed ID: 2888455
[TBL] [Abstract][Full Text] [Related]
8. T11TS, the cell surface molecule binding to the "erythrocyte receptor" of T lymphocytes: cellular distribution, purification to homogeneity and biochemical properties.
Hünig T; Mitnacht R; Tiefenthaler G; Köhler C; Miyasaka M
Eur J Immunol; 1986 Dec; 16(12):1615-21. PubMed ID: 2880724
[TBL] [Abstract][Full Text] [Related]
9. [Isolation and expansion of glioma-infiltrating lymphocytes in vitro: an analysis of their surface phenotypes and antitumor activities].
Sawamura Y
Hokkaido Igaku Zasshi; 1991 Nov; 66(6):868-78. PubMed ID: 1783372
[TBL] [Abstract][Full Text] [Related]
10. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
[TBL] [Abstract][Full Text] [Related]
11. X-irradiation to human malignant glioma cells enhances the cytotoxicity of autologous killer lymphocytes under specific conditions.
Ishikawa E; Tsuboi K; Saijo K; Takano S; Ohno T
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1505-12. PubMed ID: 15275738
[TBL] [Abstract][Full Text] [Related]
12. A mathematical model to elucidate brain tumor abrogation by immunotherapy with T11 target structure.
Banerjee S; Khajanchi S; Chaudhuri S
PLoS One; 2015; 10(5):e0123611. PubMed ID: 25955428
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapeutic effects of T11TS/S-LFA3 against nitrosocompound mediated neural genotoxicity.
Mukherjee J; Sarkar S; Ghosh A; Duttagupta AK; Chaudhuri S; Chaudhuri S
Toxicol Lett; 2004 May; 150(3):239-57. PubMed ID: 15110076
[TBL] [Abstract][Full Text] [Related]
14. Disease relevance of T11TS-induced T-cell signal transduction through the CD2-mediated calcineurin-NFAT pathway: Perspectives in glioma immunotherapy.
Chaudhuri S; Bhattacharya D; Singh MK; Moitra S; Ronsard L; Ghosh TK; Chaudhuri S
Mol Immunol; 2015 Oct; 67(2 Pt B):256-64. PubMed ID: 26105805
[TBL] [Abstract][Full Text] [Related]
15. [Separation and functional analysis of tumor-infiltrating lymphocytes in brain tumor tissues].
Saito T; Tanaka R; Takai N; Hara N; Yoshida S
No To Shinkei; 1988 Dec; 40(12):1137-42. PubMed ID: 3266842
[TBL] [Abstract][Full Text] [Related]
16. The ligand of the erythrocyte receptor of T lymphocytes: expression on white blood cells and possible involvement in T cell activation.
Hünig TR
J Immunol; 1986 Mar; 136(6):2103-8. PubMed ID: 2936820
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity and surface phenotypes of human glioma-infiltrating lymphocytes after in vitro expansion in the presence of interleukin 2.
Sawamura Y; Hosokawa M; Kuppner MC; Kobayashi H; Aida T; Abe H; de Tribolet N
Cancer Res; 1989 Apr; 49(7):1843-9. PubMed ID: 2784352
[TBL] [Abstract][Full Text] [Related]
18. Sheep form of leucocyte function antigen-3 (T11TS) exerts immunostimulatory and anti-tumor activity against experimental brain tumor. A new approach to biological response modifier therapy.
Sarkar S; Begum Z; Dutta S; Dutta SK; Chaudhuri S; Chaudhuri S
J Exp Clin Cancer Res; 2002 Mar; 21(1):95-106. PubMed ID: 12071536
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with T11TS / S-LFA-3 specifically induces apoptosis of brain tumor cells by augmenting intracranial immune status.
Mukherjee J; Ghosh A; Sarkar P; Mazumdar M; Banerjee C; Chaudhuri S
Anticancer Res; 2005; 25(4):2905-19. PubMed ID: 16080544
[TBL] [Abstract][Full Text] [Related]
20. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
